Cancer Risk After Midurethral Sling Surgery Using Polypropylene Mesh

Area of Science:

• Urogynecology
• Oncology
• Medical Device Safety

Background:

• Stress urinary incontinence (SUI) is a common condition affecting women.
• Synthetic polypropylene mesh slings are widely used for SUI treatment.
• Concerns exist regarding potential long-term health risks, including cancer, associated with mesh implantation.

Purpose of the Study:

• To investigate the association between midurethral polypropylene mesh sling implantation for SUI and the subsequent risk of developing cancer.
• To evaluate cancer risk across various organ systems following mesh surgery.

Main Methods:

• Nationwide cohort study in Sweden (1997-2009) including over 5 million women.
• Compared cancer incidence in 20,905 women who underwent mesh sling surgery (exposed) versus the general female population (unexposed).
• Utilized Cox proportional hazards regression to calculate hazard ratios (HRs) and 95% confidence intervals (CIs).

Main Results:

• No significant increase in the overall risk of primary cancer was observed in women exposed to polypropylene mesh slings.
• An inverse association was noted with rectal cancer (HR 0.5, 95% CI 0.3-0.8).
• Specific pelvic organ cancer risks (ovarian, endometrial, cervical) and bladder/urethra cancer risks did not show significant increases.

Conclusions:

• Midurethral polypropylene sling surgery for SUI is not associated with an elevated cancer risk.
• The findings support the safety profile of these devices regarding cancer development.
• Further research may explore the inverse association with rectal cancer.